PLIANT THERAPEUTICS INC (PLRX) Stock Analyst Ratings
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to PLRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.29. This target is 1208.12% above the current price.
PLRX was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PLRX.
In the previous month the buy percentage consensus was at a similar level.
PLRX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Needham | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-10 | Needham | Maintains | Buy -> Buy |
| 2025-02-10 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-02-10 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-02-10 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-02-10 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-02-10 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-02-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-08 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-08-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-16 | Needham | Reiterate | Buy -> Buy |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | Needham | Reiterate | Buy -> Buy |
| 2024-05-07 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-07 | Citigroup | Maintains | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-12 | Needham | Reiterate | Buy -> Buy |
| 2024-03-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | Needham | Reiterate | Buy -> Buy |
| 2024-02-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |